Executive VP also led Pharma and Global Market Access group
“With the restructuring of our Pharma and Global Market Access group, Jeff Berkowitz, who has led that function since its formation, has made the decision to pursue other opportunities outside the company,” Walgreens Boots Alliance said in a statement. “We are moving key components within Pharma and Global Market Access to their relevant business units in order to take advantage of rapid changes in the global health and pharma market, and to bring strategic decision-making closer to the divisional business units.
“We thank Jeff for his contributions to both Walgreens and Walgreens Boots Alliance during an important transitional time for our companies.”
Berkowitz joined Walgreens in 2010 as senior vice president of pharmaceutical development and market access. He had been senior vice president of global market access at Merck & Co. He was a member of the Merck Global Human Health Leadership Team, which was accountable for all activity related to access, pricing, payer marketing, health outcomes and health technology assessments worldwide.
From 2002 to 2009, Berkowitz held a variety of positions in market access, sales and marketing with Schering-Plough. His tenure there led to his role as group vice president of diversified products and global market access. He also served as legal director for Schering-Plough’s managed care and commercial group from 1998 to 2002. Prior to joining Schering-Plough, Berkowitz was a health care attorney for the international law firm Proskauer Rose LLP.